David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
American Journal of Bioethics 8 (6):5 – 8 (2008)
Myriad Genetics holds a patent on testing for the hereditary breast and ovarian cancer genes, BRCA1 and BRCA2, and therefore has a forced monopoly on this critical genetic test. Myriad launched a Direct-to-Consumer (DTC) marketing campaign in the Northeast United States in September 2007 and plans to expand that campaign to Florida and Texas in 2008. The ethics of Myriad's patent, forced monopoly and DTC campaign will be reviewed, as well as the impact of this situation on patient access and care, physician liability, and the future of DTC campaigns for genetic testing.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
Howard Brody (2008). Ask Your Doctor If This Genetic Test is Right for You. American Journal of Bioethics 8 (6):1 – 2.
Similar books and articles
George Munchus (1989). Testing as a Selection Tool: Another Old and Sticky Managerial Human Rights Issue. [REVIEW] Journal of Business Ethics 8 (10):817 - 820.
Gordon Storholm & Hershey Friedman (1989). Perceived Common Myths and Unethical Practices Among Direct Marketing Professionals. Journal of Business Ethics 8 (12):975 - 979.
Jin Seong Park & Jean M. Grow (2008). The Social Reality of Depression: Dtc Advertising of Antidepressants and Perceptions of the Prevalence and Lifetime Risk of Depression. [REVIEW] Journal of Business Ethics 79 (4):379 - 393.
Paula Boddington & Susan Hogben (2006). Working Up Policy: The Use of Specific Disease Exemplars in Formulating General Principles Governing Childhood Genetic Testing. [REVIEW] Health Care Analysis 14 (1):1-13.
Richard F. Beltramini (2006). Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs. Journal of Business Ethics 63 (4):333 - 343.
Cheryl Berg & Kelly Fryer-Edwards (2008). The Ethical Challenges of Direct-to-Consumer Genetic Testing. Journal of Business Ethics 77 (1):17 - 31.
Frances M. Alexakos (2003). Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer. Dissertation, Salve Regina University
Frances M. Alexakos, Attitudes of Rhode Island Primary Care Physicians Toward the Use of Genetic Testing for Breast Cancer.
Bryn Williams-Jones & Michael M. Burgess (2004). Social Contract Theory and Just Decision Making: Lessons From Genetic Testing for the BRCA Mutations. Kennedy Institute of Ethics Journal 14 (2):115-142.
Michelle L. McGowan & Jennifer R. Fishman (2008). Using Lessons Learned From Brca Testing and Marketing: What Lies Ahead for Whole Genome Scanning Services. American Journal of Bioethics 8 (6):18 – 20.
Added to index2009-01-28
Total downloads11 ( #146,995 of 1,168,893 )
Recent downloads (6 months)1 ( #140,419 of 1,168,893 )
How can I increase my downloads?